Effect of endurance training and ginger on lipid peroxidation in Sedentary people

Effect of endurance training and ginger consumption on lipid peroxidation and some indicators of cellular damage in Sedentary people

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016011221412N4

Enrollment

120

Registered

2016-06-03

Start date

2014-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Routine general health check-up of students. Routine general health check-up of other defined subpopulations

Interventions

Intervention 1: intervention group 1, 30 healthy male students that ingest two capsules contain 500 milligram ginger powder each day after breakfast and dinner during one month. Intervention 2: inter

Placebo

intervention group 1, 30 healthy male students that ingest two capsules contain 500 milligram ginger powder each day after breakfast and dinner during one month

intervention group 2, 30 healthy male students that ingest two capsules contain 500 milligram starch each day after breakfast and dinner during one month

intervention group 3, 30 healthy male students that ingest two capsules contain 500 milligram ginger powder each day after breakfast and dinner with regular endurance training during one month

intervention group 4, 30 healthy male students that ingest two capsules contain 500 milligram starch each day after breakfast and dinner with regular endurance training during one month

Eligibility

Sex/Gender

Male

Age

30 Years to 32 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: male gender between the ages 30-32 year old; healthy, nonsmokers and non-athlete people; with BMI less than 30. Exclusion criteria: athlete people with normal medicine usage; any history of disease such respiratory cardiac; high blood pressure; use of smoking

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Creatine kinase level. Timepoint: After and before one month of continuous treatment. Method of measurement: Blood test by using a Pars Azmoon biochemical kit (Pars Azmoon Co., Tehran, Iran).;Malondialdehyde (MDA) level. Timepoint: After and before one month of continuous treatment. Method of measurement: Blood test by using thiobarbituric acid method.;Lactate Dehydrogenase (LDH). Timepoint: After and before one month of continuous treatment. Method of measurement: Blood test by using a Pars Azmoon biochemical kit (Pars Azmoon Co., Tehran, Iran).	—

Measure

Time frame

Creatine kinase level. Timepoint: After and before one month of continuous treatment. Method of measurement: Blood test by using a Pars Azmoon biochemical kit (Pars Azmoon Co., Tehran, Iran).;Malondialdehyde (MDA) level. Timepoint: After and before one month of continuous treatment. Method of measurement: Blood test by using thiobarbituric acid method.;Lactate Dehydrogenase (LDH). Timepoint: After and before one month of continuous treatment. Method of measurement: Blood test by using a Pars Azmoon biochemical kit (Pars Azmoon Co., Tehran, Iran).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamid Kalalian Moghadam

Shahroud University of Medical Sciences

h.kalalian@shmu.ac.ir+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026